Lepletier, Ailin, Lutzky, Viviana P., Mittal, Deepak, Stannard, Kimberley, Watkins, Thomas, Ratnatunga, Champa N., Smith, Corey, McGuire, Helen M., Kemp, Roslyn A., Mukhopadhyay, Pamela, Waddell, Nicola, Smyth, Mark J., Dougall, William C., and Miles, John J. (2019) The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor-infiltrating T cells. Immunology and Cell Biology, 97 (2). pp. 152-164.

Blake, Stephen J., Dougall, William C., Miles, John J., Teng, Michele W.L., and Smyth, Mark J. (2016) Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy. Clinical Cancer Research, 22 (21). pp. 5183-5188.